Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Statoil To Sell Stakes In Several Fields Offshore Norway To OMV For $2.65 Bln

RELATED NEWS
Trade STO now with 

Statoil ASA (STO: Quote) said Monday that it has signed an agreement to divest minority interests in several fields offshore Norway to Austrian oil and gas company OMV for $2.65 billion in cash.

Statoil said it will divest minority interests in the Gullfaks and Gudrun fields offshore Norway and exit the non-core, non-operated Schiehallion and Rosebank fields, West of Shetlands.

In addition, the transaction with OMV includes a contingent payment and involves a partnership between the two companies. Statoil noted that it reduces its ownership share in Gullfaks to 51 % from 70 % and to 51 % from 75 % in Gudrun, and retains its operatorships on both fields.

Statoil said it expects to recognize a gain from the transaction estimated to be between $1.3 billion - $1.5 billion, to be adjusted for activity between the effective date 1 January 2013 and the closing date.

The company noted that the transaction will enable it to redeploy around $7 billion of capital expenditure, around $5.5 billion of which is pre-2020, excluding potential investments in the recent Shetland/Lista discovery at Gullfaks.

OMV is an established company on both the Norwegian or NCS and the UK (UKCS) continental shelves.

Statoil and OMV enter into a partnership including potential cooperation on exploration opportunities across Norway, the UK and the Faroese Islands as well as the development of Enhanced Oil Recovery or EOR technologies.

Register
To receive FREE breaking news email alerts for Statoil ASA and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Micro-blogging site Twitter Inc said Tuesday after the markets closed that its second quarter loss widened from last year, hurt mainly by stock-based compensation expense, even as revenue more than doubled thanks to growth in advertising. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Pharmaceutical giant Pfizer, Inc., which was aspiring to buy British drug maker AstraZeneca Plc, reported Tuesday a profit for the second quarter that plunged 79 percent from last year, which reflected hefty gains from animal health business sales. Total revenues declined 2 percent, as it continued to be hurt by generic competition for major drugs. Home improvement and building products company Masco Corp. said Monday after the markets closed that its second quarter profit jumped 78% from last year, as revenue increased and margins improved amid strong performance of its Plumbing Products, Installation and Other Services and Decorative Architectural Products segments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.